125 related articles for article (PubMed ID: 6410790)
1. Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas.
Patronas NJ; Brooks RA; DeLaPaz RL; Smith BH; Kornblith PL; Di Chiro G
AJNR Am J Neuroradiol; 1983; 4(3):533-5. PubMed ID: 6410790
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic studies of gliomas with positron emission tomography and phosphorus 31 MR spectroscopy in diagnosis and treatment planning].
Jeske J; Herholz K; Heindel W; Heiss WD
Onkologie; 1989 Aug; 12 Suppl 1():42-5. PubMed ID: 2685695
[TBL] [Abstract][Full Text] [Related]
3. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
Song PJ; Lu QY; Li MY; Li X; Shen F
J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
[TBL] [Abstract][Full Text] [Related]
4. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography.
Tovi M; Lilja A; Bergström M; Ericsson A; Bergström K; Hartman M
Acta Radiol; 1990 Sep; 31(5):417-29. PubMed ID: 2261284
[TBL] [Abstract][Full Text] [Related]
5. EEG, transmission computed tomography, and positron emission tomography with fluorodeoxyglucose 18F. Their use in adults with gliomas.
Newmark ME; Theodore WH; Sato S; De La Paz R; Patronas N; Brooks R; Jabbari B; Di Chiro G
Arch Neurol; 1983 Oct; 40(10):607-10. PubMed ID: 6615267
[TBL] [Abstract][Full Text] [Related]
6. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
Herholz K; Rudolf J; Heiss WD
J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
[TBL] [Abstract][Full Text] [Related]
7. 11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds.
Voges J; Herholz K; Hölzer T; Würker M; Bauer B; Pietrzyk U; Treuer H; Schröder R; Sturm V; Heiss WD
Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):129-35. PubMed ID: 9711745
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
[TBL] [Abstract][Full Text] [Related]
10. F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI.
Santra A; Kumar R; Sharma P; Bal C; Kumar A; Julka PK; Malhotra A
Eur J Radiol; 2012 Mar; 81(3):508-13. PubMed ID: 21353420
[TBL] [Abstract][Full Text] [Related]
11. Tumour delineation with magnetic resonance imaging in gliomas. A comparison with positron emission tomography and computed tomography.
Tovi M; Thuomas KA; Bergström K; Lilja A; Bergström M; Lundqvist H; Långström B
Acta Radiol Suppl; 1986; 369():161-3. PubMed ID: 2980439
[TBL] [Abstract][Full Text] [Related]
12. Advances in imaging low-grade gliomas.
Price SJ
Adv Tech Stand Neurosurg; 2010; 35():1-34. PubMed ID: 20102109
[TBL] [Abstract][Full Text] [Related]
13. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
[TBL] [Abstract][Full Text] [Related]
14. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
Di Chiro G; DeLaPaz RL; Brooks RA; Sokoloff L; Kornblith PL; Smith BH; Patronas NJ; Kufta CV; Kessler RM; Johnston GS; Manning RG; Wolf AP
Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
Heiss WD; Heindel W; Herholz K; Rudolf J; Bunke J; Jeske J; Friedmann G
J Nucl Med; 1990 Mar; 31(3):302-10. PubMed ID: 2308001
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions.
Lilja A; Lundqvist H; Olsson Y; Spännare B; Gullberg P; Långström B
Acta Radiol; 1989; 30(2):121-8. PubMed ID: 2493795
[TBL] [Abstract][Full Text] [Related]
17. Fluorine-18-deoxyglucose positron emission tomography/computed tomography with Ki67 and GLUT-1 immunohistochemistry for evaluation of the radiosensitization effect of oleanolic acid on C6 rat gliomas.
Zhang Y; Xu H; Wang H; Yu W; Zhao X; Xue Y
Nucl Med Commun; 2015 Jan; 36(1):21-7. PubMed ID: 25222909
[TBL] [Abstract][Full Text] [Related]
18. MR imaging in cerebral gliomas analysis of tumour tissue components.
Tovi M
Acta Radiol Suppl; 1993; 384():1-24. PubMed ID: 8493882
[TBL] [Abstract][Full Text] [Related]
19. (18)F-Fluorothymidine PET-CT for resected malignant gliomas before radiotherapy: tumor extent according to proliferative activity compared with MRI.
Zhao F; Li M; Wang Z; Fu Z; Cui Y; Chen Z; Yu J
PLoS One; 2015; 10(3):e0118769. PubMed ID: 25738617
[TBL] [Abstract][Full Text] [Related]
20. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD
Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]